Richard Treisman

{{Short description|British scientist}}

{{Use dmy dates|date=February 2020}}

{{EngvarB|date=February 2020}}

{{Infobox scientist

| name = Sir Richard Treisman

| image = Sir_Richard_Treisman.jpg

| image_size =

| alt = Sir Richard Treisman speaking at a conference in 2015

| caption = Treisman in 2015

| honorific_suffix = {{post-nominals|country=GBR|FRS|FMedSci|size=100%}}

| birth_date = {{Birth date and age|df=y|1954|10|07}}{{Who's Who | author=Anon| title=Treisman, Dr Richard Henry | id = U37996 | year = 2017 | doi =10.1093/ww/9780199540884.013.37996 | edition = online Oxford University Press|location=Oxford}}

| thesis_title = The structures of polyoma virus-specific nuclear and cytoplasmic RNA molecules

| thesis_url = http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.290828

| thesis_year = 1981

| alma_mater = Christ's College, Cambridge
University College London

| education = Haberdashers' Aske's Boys' School

| workplaces = Francis Crick Institute
Harvard University
University of Cambridge
Laboratory of Molecular Biology

| awards = {{Plainlist|

| doctoral_advisor = Bob Kamen{{cite web|url=http://blueskiesbenchspace.org/blog/?p=164|title=Voices of the Fifth Floor – Blue Skies and Bench Space|website=blueskiesbenchspace.org}}

| academic_advisors = Tom Maniatis

| doctoral_student =

| notable_students = Richard Marais{{cite journal|last1=Larue|first1=Lionel|title=Richard Marais|journal=Pigment Cell & Melanoma Research|volume=23|issue=3|year=2010|pages=448|issn=1755-1471|doi=10.1111/j.1755-148X.2010.00708.x|pmid=20518862|doi-access=free}}

| website = {{URL|www.crick.ac.uk/research/a-z-researchers/researchers-t-u/richard-treisman/}}

}}

Sir Richard Henry Treisman (born 7 October 1954) is a British scientist specialising in the molecular biology of cancer. Treisman is a director of research at the Francis Crick Institute in London.

Education

Treisman was educated at Haberdashers' Aske's Boys' School and Christ's College, Cambridge, where he was awarded a Bachelor of Arts degree in 1977. He completed his postgraduate study at the Imperial Cancer Research Fund (ICRF) and University College London, where he was awarded a PhD for research on polyomavirus transcription and RNA processing supervised by Bob Kamen in 1981.{{cite thesis|degree=PhD|publisher=University College London (University of London)|title=The structures of polyoma virus-specific nuclear and cytoplasmic RNA molecules|first= Richard Henry|last=Treisman|year=1981|url=http://catalogue.libraries.london.ac.uk/record=b1523865|id={{EThOS|uk.bl.ethos.290828}}|oclc=556387169|website=london.ac.uk}}

Career and research

After his PhD, Treisman pursued postdoctoral research at Harvard University on globin gene expression and thalassemia genes with Tom Maniatis. In 1984, he joined the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) at the University of Cambridge, where he started working on how growth factors control transcription. Initially focusing on the Fos gene, he identified the transcription factor Serum response factor (SRF) and cloned its gene, before returning to London in 1988.{{cite web|url=https://royalsociety.org/people/richard-treisman-12432/|title=Richard Treisman|website=royalsociety.org|archiveurl=https://web.archive.org/web/20171027224902/https://royalsociety.org/people/richard-treisman-12432/|archivedate=27 October 2017|publisher=Royal Society|author=Anon|location=London|year=1994|accessdate=27 May 2018}} One or more of the preceding sentences incorporates text from the royalsociety.org website where: {{blockquote|"All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License." --{{Webarchive|url=https://web.archive.org/web/20161111170346/https://royalsociety.org/about-us/terms-conditions-policies/|title=Royal Society Terms, conditions and policies|date=2016-11-11}}}}

He showed that the TCF family of SRF cofactors are targets for Mitogen-activated protein kinase (MAPK) signalling, and demonstrated that the MRTF transcription cofactors are novel G-actin binding proteins that sense fluctuations in G-actin concentration. He continues to focus on SRF's regulatory cofactors and their cognate signalling pathways.

Treisman was Director of the Cancer Research UK (CRUK) London Research Institute from 2000 to 2015, becoming Research Director of the Francis Crick Institute in 2009.

=Awards and honours=

Treisman was elected a member of the European Molecular Biology Organization{{when|date=May 2018}} and a Fellow of the Academy of Medical Sciences (FMedSci);{{when|date=May 2018}} he received the EMBO Gold Medal in 1995{{Cite journal|last=Treisman|first=Richard|year=1995|title=Journey to the surface of the cell: Fos regulation and the SRE | journal=The EMBO Journal|volume=14|issue=20|pages=4905–4913 |pmc=394592|pmid=7588619 |doi=10.1002/j.1460-2075.1995.tb00173.x}} and the Louis-Jeantet Prize for Medicine in 2002.[https://www.jeantet.ch/en/prix-louis-jeantet/laureats/2002-en/docteur-richard-treisman/ Louis-Jeantet Prize] He was elected a Fellow of the Royal Society (FRS) in 1994 and knighted in the 2016 Birthday Honours.{{London Gazette |issue= 61608 |date=11 June 2016 |page=B2}}{{cite web|url=https://www.bbc.co.uk/news/health-36499807|publisher=BBC|title=Birthday honours: Mitochondrial disease doctor recognised|year=2016|author=Anon}}

References

{{Reflist}}

{{CC-notice|cc=by4|url= https://royalsociety.org/people/richard-treisman-12432/}}

{{Francis Crick Institute}}

{{FRS 1994}}

{{Authority control}}

{{DEFAULTSORT:Treisman, Richard Henry}}

Category:1954 births

Category:Living people

Category:People educated at Haberdashers' Boys' School

Category:Alumni of Christ's College, Cambridge

Category:Alumni of University College London

Category:Fellows of the Royal Society

Category:Knights Bachelor

Category:Academics of the Francis Crick Institute